Home
News
Create
Screeners
Insights
Shree Ganesh Bio-Tech
0.
63
-0.01
(-1.56%)
Market Cap
₹- Cr
PE Ratio
-
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-1.56%
1M
-13.70%
6M
-28.41%
1Y
-44.74%
5Y
-87.57%
View Company Insights
Latest news about Shree Ganesh Bio-Tech
Shree Ganesh Bio-Tech Reports Revenue Decline in Q2 FY2026
Nov 08, 2025
Shree Ganesh Bio-Tech (India) Limited announced unaudited financial results for Q2 and H1 FY2026. Revenue from operations decreased by 61.32% to Rs. 76.74 lakhs in Q2 FY2026 from Rs. 198.40 lakhs in Q2 FY2025. Net profit after tax fell by 95.64% to Rs. 1.41 lakhs in Q2 FY2026 from Rs. 32.34 lakhs in Q2 FY2025. For H1 FY2026, revenue dropped 61.17% to Rs. 215.10 lakhs, while profit before tax decreased by 39.22% to Rs. 34.11 lakhs compared to H1 FY2025. Other income increased to Rs. 41.01 lakhs in Q2 FY2026 from Rs. 30.29 lakhs in Q2 FY2025. The company's total assets stood at Rs. 6,513.75 lakhs with an equity base of Rs. 6,359.70 lakhs as of September 30, 2025.
Shree Ganesh Biotech Reports 37.5% Jump in Net Profit for Quarter Ended June
Jul 25, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation